Pressure Biosciences Inc (PBIO) financial statements (2022 and earlier)
Company profile
| Business Address |
14 NORFOLK AVENUE SOUTH EASTON, MA 02375 |
| State of Incorp. | MA |
| Fiscal Year End | December 31 |
| SIC | 3826 - Laboratory Analytical Instruments (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 19 | 30 | 103 | 81 | 138 | 117 | |||
| Cash and cash equivalents | 19 | 30 | 103 | 81 | 138 | 117 | |||
| Receivables | 131 | 229 | 475 | 207 | 281 | 113 | |||
| Inventory, net of allowances, customer advances and progress billings, including: | 593 | 69 | 94 | 160 | 905 | 1,038 | |||
| Inventory | 593 | 618 | 765 | 858 | 905 | 1,038 | |||
| Other undisclosed inventory, net of allowances, customer advances and progress billings | (549) | (672) | (698) | ||||||
| Prepaid expense | 7 | 7 | 7 | ||||||
| Intangible current assets | 577 | 663 | 750 | ||||||
| Other undisclosed current assets | 315 | 185 | 179 | 163 | 258 | 214 | |||
| Total current assets: | 1,057 | 1,090 | 1,514 | 1,368 | 1,590 | 1,490 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 221 | 77 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 16 | 56 | 69 | 23 | 9 | 20 | |||
| Long-term investments and receivables | 517 | 17 | 17 | 20 | 26 | 295 | |||
| Long-term investments | 517 | 17 | 17 | 20 | 26 | 295 | |||
| Intangible assets, net (including goodwill) | 490 | 577 | 663 | 750 | |||||
| Intangible assets, net (excluding goodwill) | 490 | 577 | 663 | 750 | |||||
| Other undisclosed noncurrent assets | 136 | ||||||||
| Total noncurrent assets: | 1,245 | 726 | 886 | 792 | 35 | 315 | |||
| TOTAL ASSETS: | 2,303 | 1,816 | 2,400 | 2,160 | 1,626 | 1,804 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,227 | 2,925 | 2,229 | 1,759 | 1,614 | 1,938 | |||
| Accounts payable | 772 | 816 | 659 | 589 | 407 | 941 | |||
| Accrued liabilities | 2,038 | 1,658 | 1,113 | 801 | 957 | 821 | |||
| Employee-related liabilities | 418 | 451 | 457 | 369 | 250 | 176 | |||
| Deferred revenue | 47 | 23 | ✕ | ✕ | ✕ | ✕ | |||
| Debt | 8,681 | 7,874 | 4,853 | 12,908 | 4,857 | 252 | |||
| Derivative instruments and hedges, liabilities | 1,685 | 3,296 | |||||||
| Due to related parties | 166 | 82 | 15 | ||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 263 | 160 | 141 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | 21 | ✕ | ✕ | ✕ | ||
| Other liabilities | 6,331 | 2,950 | 1,233 | 1,537 | |||||
| Other undisclosed current liabilities | 65 | 260 | 951 | 3,941 | |||||
| Total current liabilities: | 18,518 | 13,853 | 8,351 | 16,726 | 9,266 | 9,568 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 156 | 530 | 177 | ||||||
| Long-term debt, excluding current maturities | 530 | 177 | |||||||
| Operating lease, liability | 156 | ✕ | ✕ | ✕ | ✕ | ||||
| Liabilities, other than long-term debt | 19 | 18 | 57 | 88 | 37 | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 57 | 88 | 37 | ||
| Deferred revenue | 19 | 18 | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 527 | 174 | 126 | ||||||
| Total noncurrent liabilities: | 703 | 18 | 174 | 57 | 743 | 214 | |||
| Total liabilities: | 19,220 | 13,871 | 8,525 | 16,783 | 10,009 | 9,782 | |||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (16,918) | (12,055) | (6,125) | (14,623) | (8,383) | (7,978) | |||
| Common stock | 42 | 25 | 17 | 13 | 310 | 230 | |||
| Additional paid in capital | 50,313 | 44,261 | 39,777 | 30,834 | 27,245 | 26,037 | |||
| Accumulated other comprehensive loss | (105) | ||||||||
| Accumulated deficit | (96,466) | (78,942) | (65,728) | (55,349) | (42,264) | (39,557) | |||
| Warrants and rights outstanding | 29,192 | 22,599 | 19,807 | 9,879 | 6,325 | 5,417 | |||
| Other undisclosed stockholders' equity attributable to parent | 1 | 1 | 1 | 1 | 1 | 1 | |||
| Total stockholders' equity: | (16,918) | (12,055) | (6,125) | (14,623) | (8,383) | (7,978) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,303 | 1,816 | 2,400 | 2,160 | 1,626 | 1,804 | |||
Income statement (P&L) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,221 | 1,810 | 2,458 | 2,240 | 1,976 | 1,798 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 2,240 | 1,976 | 1,798 | |
| Cost of revenue (Cost of Goods and Services Sold) | (583) | (1,197) | (1,280) | (1,273) | (834) | (609) | ||
| Gross profit: | 638 | 613 | 1,178 | 967 | 1,142 | 1,189 | ||
| Operating expenses | (5,224) | (7,616) | (6,935) | (6,888) | (5,712) | (5,363) | ||
| Other undisclosed operating income | 1,197 | 1,280 | 1,273 | 834 | 609 | |||
| Operating loss: | (4,586) | (5,806) | (4,477) | (4,647) | (3,736) | (3,565) | ||
| Nonoperating income (expense) | (11,420) | (6,073) | (5,222) | (6,069) | 1,029 | (3,850) | ||
| Interest and debt expense | (11,920) | (795) | 260 | 185 | (5) | (4,146) | ||
| Loss from continuing operations before income taxes: | (27,926) | (12,673) | (9,439) | (10,530) | (2,712) | (11,562) | ||
| Income tax benefit | 217 | |||||||
| Loss before gain (loss) on sale of properties: | (27,926) | (12,456) | (9,439) | (10,530) | (2,712) | (11,562) | ||
| Other undisclosed net income (loss) | 10,341 | (3,412) | (14,034) | |||||
| Net loss: | (17,585) | (15,868) | (23,473) | (10,530) | (2,712) | (11,562) | ||
| Other undisclosed net income (loss) attributable to parent | 1,579 | 4,207 | 13,774 | (185) | 5 | 4,146 | ||
| Net loss attributable to parent: | (16,006) | (11,661) | (9,699) | (10,716) | (2,707) | (7,415) | ||
| Preferred stock dividends and other adjustments | (1,518) | (1,554) | (679) | (23) | ||||
| Other undisclosed net loss available to common stockholders, basic | (61) | (2,653) | (13,095) | |||||
| Net loss available to common stockholders, diluted: | (17,585) | (15,868) | (23,473) | (10,716) | (2,707) | (7,438) | ||
Comprehensive Income ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (17,585) | (15,868) | (23,473) | (10,530) | (2,712) | (11,562) | ||
| Comprehensive loss: | (17,585) | (15,868) | (23,473) | (10,530) | (2,712) | (11,562) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (185) | 110 | 4,041 | |||||
| Comprehensive loss, net of tax, attributable to parent: | (17,585) | (15,868) | (23,473) | (10,716) | (2,602) | (7,520) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.